These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20039893)

  • 1. The metabolic syndrome is associated with subclinical atherosclerosis independent of insulin resistance: the Guangzhou Biobank Cohort Study-CVD.
    Xu L; Jiang CQ; Lam TH; Lin JM; Yue XJ; Cheng KK; Liu B; Jin YL; Zhang WS; Thomas GN;
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):181-8. PubMed ID: 20039893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Bertoni AG; Wong ND; Shea S; Ma S; Liu K; Preethi S; Jacobs DR; Wu C; Saad MF; Szklo M
    Diabetes Care; 2007 Nov; 30(11):2951-6. PubMed ID: 17704348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes.
    Ingelsson E; Sullivan LM; Murabito JM; Fox CS; Benjamin EJ; Polak JF; Meigs JB; Keyes MJ; O'Donnell CJ; Wang TJ; D'Agostino RB; Wolf PA; Vasan RS
    Diabetes; 2007 Jun; 56(6):1718-26. PubMed ID: 17369522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
    J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of insulin resistance in the obese with metabolic syndrome.
    Manu P; Tsang J; Napolitano BA; Lesser ML; Correll CU
    Eur J Intern Med; 2010 Oct; 21(5):409-13. PubMed ID: 20816595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.
    Zarich SW
    Minerva Cardioangiol; 2006 Apr; 54(2):195-214. PubMed ID: 16778752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
    Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MetS and cardiovascular risk factors among Palestinians of East Jerusalem.
    Abu Sham'a RA; Darwazah AK; Kufri FH; Yassin IH; Torok NI
    East Mediterr Health J; 2009; 15(6):1464-73. PubMed ID: 20218139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of physical fitness and the metabolic syndrome to predict vascular disease risk in older Chinese (from the Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort [GBCS-CVD]).
    O'Hartaigh B; Jiang CQ; Thomas GN; Tsvetanov KA; Bosch JA; Cheng KK; Lam TH
    Am J Cardiol; 2011 Sep; 108(6):845-50. PubMed ID: 21784386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiometabolic syndrome in the adolescent.
    Gardner M; Gardner DW; Sowers JR
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():964-8. PubMed ID: 18806711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of features of the metabolic syndrome on atherosclerotic risk in relatively long-surviving patients with type 1 diabetes.
    Distiller LA; Joffe BI; Brown V; Distiller GB
    Metab Syndr Relat Disord; 2010 Dec; 8(6):539-43. PubMed ID: 20818972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and cardiovascular disease.
    Qiao Q; Gao W; Zhang L; Nyamdorj R; Tuomilehto J
    Ann Clin Biochem; 2007 May; 44(Pt 3):232-63. PubMed ID: 17456293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the metabolic syndrome construct: Multi-Ethnic Study of Atherosclerosis (MESA) cross-sectional analysis.
    Vaidya D; Szklo M; Liu K; Schreiner PJ; Bertoni AG; Ouyang P
    Diabetes Care; 2007 Aug; 30(8):2086-90. PubMed ID: 17485573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
    Song SH; Hardisty CA
    QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The polycystic ovary syndrome--metabolic consequences].
    Tan S; Hahn S; Janssen OE
    Gynakol Geburtshilfliche Rundsch; 2008; 48(1):16-23. PubMed ID: 18209495
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
    Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
    Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carotid atherosclerosis associated to metabolic syndrome but not BMI in healthy menopausal women.
    Montalcini T; Gorgone G; Gazzaruso C; Sesti G; Perticone F; Pujia A
    Diabetes Res Clin Pract; 2007 Jun; 76(3):378-82. PubMed ID: 17034893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the clinical usefulness of the metabolic syndrome? The Casale Monferrato study.
    Bruno G; Fornengo P; Segre O; Novelli G; Panero F; Perotto M; Zucco C; Bargero G; Cavallo-Perin P
    J Hypertens; 2009 Dec; 27(12):2403-8. PubMed ID: 19738492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.